title: Bevacizumab for retinopathy of prematurity.
authors.forename: James D
authors.initials: JD
authors.lastname: Reynolds
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections; D053685:Laser Therapy / Q000009:adverse effects; D012008:Recurrence; D012160:Retina / Q000473:pathology; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000628:therapy
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab